{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-140076","form_type":"8-K","ticker":null,"cik":"0000891293","company_name":"CTI BIOPHARMA CORP","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.674286+00:00","generated_at":"2026-06-15T07:37:42.594363+00:00","sec_items":["1.01","5.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"CTI BioPharma to be acquired by Sobi for $9.10 per share in cash","bullets":["Offer price of $9.10 per share in cash through a tender offer and subsequent merger.","Minimum condition requires tender of shares representing >50% of outstanding plus certain convertible securities.","CTI must pay Sobi a $59 million termination fee if it accepts a superior offer.","Stockholders representing 6.7% of shares entered into a support agreement to tender their shares.","Board amended bylaws to add exclusive forum provision for Delaware Chancery Court."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-140076","json":"https://secwatch.observer/filing/0001193125-23-140076.json","markdown":"https://secwatch.observer/filing/0001193125-23-140076.md","text":"https://secwatch.observer/filing/0001193125-23-140076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/891293/000119312523140076/0001193125-23-140076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/891293/000119312523140076/d436727d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T07:37:42.594363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b68f7929473aa91c0beb3cd318d4af824097fb01","claim":"CTI BIOPHARMA CORP: Board approved amendment to bylaws to add forum selection provision designating Delaware courts as exclusive forum for certain actions (effective 2023-05-09).","evidence_excerpt":"On May 9, 2023, CTI’s board of directors approved an amendment to the CTI’s Amended and Restated Bylaws, dated as of April 13, 2020 (as further amended, the “Bylaws”), to add a new Article XIII, Section 13.1 forum selection provision (the “Forum Selection Amendment”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/891293/000119312523140076/0001193125-23-140076-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-05-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}